LAVA Therapeutics N.V. (LVTX) Tops Q1 EPS by 19c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Goldman's GPIQ returns 20% in a year — and still pays a 9.47% yield at 0.29% fees
• Cognizant launches AI governance platform for enterprises
• Trump discloses over $1.4 billion in crypto income in 2025 filing